Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Pharmacovigilance01:19

Pharmacovigilance

974
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
974
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
Clinical Trials01:16

Clinical Trials

7.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.1K
Global Regulatory Systems01:28

Global Regulatory Systems

69
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
69

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanozymes for Advanced Hemoglobin-Based Oxygen Carriers: Applications in Blood Substitution, Wound Healing, Antitumor Therapy, and Beyond.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Hemoglobin-loaded ZIF-8 nanoparticles functionalized with human serum albumin as stealth, stable, and biocompatible oxygen carriers.

Nanoscale advances·2025
Same author

In vitro and in vivo investigations of hemoglobin-loaded PEGylated ZIF-8 nanoparticles as oxygen carriers for emergency transfusion.

Biomaterials advances·2024
Same author

Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee: Developed in collaboration with the European Heart Rhythm Association (EHRA), the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC, the Heart Failure Association (HFA) of the ESC, the ESC Young Community, the ESC Working Group on e-Cardiology, the ESC Council for Cardiology Practice, the ESC Council of Cardio-Oncology, the ESC Council on Hypertension, the ESC Patient Forum, the ESC Digital Health Committee, and the European Association of Preventive Cardiology (EAPC).

European heart journal. Digital health·2024
Same author

Nitric oxide-triggering activity of gold-, platinum- and cerium oxide-nanozymes from S-nitrosothiols and diazeniumdiolates.

Colloids and surfaces. B, Biointerfaces·2024
Same author

Companion Diagnostics: State of the Art and New Regulations.

Biomarker insights·2021

Related Experiment Video

Updated: Sep 5, 2025

A Standardized Protocol for Preference Testing to Assess Fish Welfare
07:29

A Standardized Protocol for Preference Testing to Assess Fish Welfare

Published on: February 22, 2020

7.0K

Preference Testing in Medical Devices: Current Framework and Regulatory Gaps.

Amy Lewis1, Despoina Douka1, Angeliki Koukoura1

  • 1Evnia, Copenhagen, Denmark.

Medical Devices (Auckland, N.Z.)
|July 13, 2022
PubMed
Summary
This summary is machine-generated.

Preference testing offers valuable insights for medical device development, improving usability and patient engagement. Establishing clear guidelines is crucial for its effective implementation in the medical field.

Keywords:
PPImedical devicepatient preferencepreference testing

More Related Videos

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.6K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

9.4K

Related Experiment Videos

Last Updated: Sep 5, 2025

A Standardized Protocol for Preference Testing to Assess Fish Welfare
07:29

A Standardized Protocol for Preference Testing to Assess Fish Welfare

Published on: February 22, 2020

7.0K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.6K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

9.4K

Area of Science:

  • Medical device development
  • Usability engineering
  • Patient-centered care

Background:

  • Preference testing is widely used in the food industry but underutilized in the medical field.
  • Limited guidelines and regulatory frameworks hinder the adoption of preference testing for medical devices.
  • Manufacturers may lack awareness of preference testing benefits or use suboptimal methodologies.

Purpose of the Study:

  • To highlight the benefits and applications of preference testing for medical devices.
  • To discuss potential methodologies for conducting preference tests on medical devices.
  • To advocate for the development of international standards and guidelines.

Main Methods:

  • This position paper reviews the current landscape of preference testing.
  • It discusses potential methods applicable to medical device preference testing.
  • It emphasizes the need for a structured approach to data collection and analysis.

Main Results:

  • Preference testing can significantly enhance medical device design, usability, and risk management.
  • Incorporating patient-relevant outcomes through preference testing increases patient engagement.
  • Standardized guidelines are essential for reliable and meaningful preference data collection.

Conclusions:

  • Preference testing is a vital tool for optimizing medical device design and clinical evaluation.
  • Wider implementation requires clear international standards for data collection and application.
  • Adopting preference testing can lead to more patient-centric and effective medical devices.